Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion

CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusion

US Patent 7935797 · Granted May 3, 2011

Estimated economic value: $3,085,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Anti-TMPRSS6 antibodies and uses thereof2025
Steroids and protein-conjugates thereof2025
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof2025
Therapeutic uses of anti-GITR antibodies2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof2025
Human antibodies to ebola virus glycoprotein2024
Tubulysins and protein-tubulysin conjugates2024
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use ther2024
VEGF traps and mini-traps and methods for treating ocular disorders and cancer2024